北美组织病理学服务市场预测至 2028 年 - COVID-19 影响和按检查类型(手术标本、乳腺活检、肺活检、肾活检、胃肠活检、胰腺活检、皮肤组织活检、睾丸活检等)进行的区域分析最终用户(诊断实验室和参比实验室、研究机构等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 109    |    Report Code: TIPRE00024561    |    Category: Life Sciences

North America Histopathology Services Market

市场介绍

组织病理学服务用于检查生物组织以诊断疾病。该程序包括组织的显微镜检查。借助成像技术,现在可以从某些难以接近的部位(例如胰腺和腹膜)获取活检组织。

 

市场概况和动态

北美组织病理学服务市场预计将从 2028 年的 92.8383 亿美元增至 139.0274 亿美元。 2021 年;预计 2021 年至 2028 年复合年增长率为 5.9%。生物制品需求增加和慢性病患病率上升等因素推动市场增长。然而,与组织病理学和免疫组织化学相关的局限性阻碍了北美组织病理学服务市场的增长。

由于生物制剂管道的扩张、增加,生物制剂的组织病理学市场正在以前所未有的速度增长。制造复杂性,以及公司重点转向核心活动。生物制品的生产出现了显着的繁荣。一旦新技术获得国内外审批机构的批准,就迫切需要扩大生产。随着越来越多的生物制品和生物仿制药进入市场,生物制药行业的竞争变得越来越激烈。生物制品制造商努力保持较低的制造成本、提供高质量的药物、提高工艺效率并加速市场进入。组织病理学家的意见在理解肿瘤生物学以及各种微生物的致病机制方面发挥着重要作用。这些发现和推论被提供组织病理学服务的专门组织所利用。据美国食品药品监督管理局统计,截至2019年9月,美国生物制药市场上已有超过350种生物制剂上市。这些药物的临床试验和药物发现程序基于在专家监督下使用高科技设备进行的内在组织病理学研究。因此,越来越多的需要组织病理学干预的生物治疗正在推动北美组织病理学服务市场的增长。此外,心血管疾病、神经系统疾病、自身免疫性疾病和癌症等慢性疾病的发病率不断上升,是全世界死亡和残疾的主要原因。研究人员和治疗师正在探索治疗这些疾病的疗法;他们进行详细的组织病理学分析,以了解这些疾病的病理生理学,从而设计治疗方法,这有助于北美组织病理学服务市场的增长。

COVID-19 大流行已经影响北美诊断行业的各个方面,包括组织病理学。在过去的几个月里,尽管医院提供急诊和 OPD 服务,但到医院就诊的患者数量却大幅减少。由于许多国家实施封锁,择期手术和癌症手术的数量大幅减少。此外,由于 COVID-19 发病率大幅增加,病理实验室现在优先考虑并专注于 COVID-19 诊断。美国和加拿大感染患者数量的快速增加阻碍了该地区组织病理学服务市场业绩的增长。

 

 

p>

主要市场细分

北美组织病理学服务市场按检查类型分为手术标本、乳腺活检、肺活检、肾活检、胃肠道活检、胰腺活检、皮肤组织活检、睾丸活检等。 2021 年,手术标本细分市场可能会占据最大的市场份额,并且预计在 2021 年至 2028 年期间将实现最高的复合年增长率。

基于最终结果对于用户来说,北美组织病理学服务市场分为诊断实验室和参考实验室、研究机构等。诊断实验室和参考实验室领域可能会在 2021 年占据最大的市场份额,并且预计在预测期内复合年增长率最高。

 

主要来源和列出的公司

一些与本北美组织病理学服务市场报告相关的主要和次要来源是疾病控制和预防中心 (CDC)、药物评价和研究中心 (CDER) 以及食品和药物管理局 (FDA)。

 

购买报告的理由< /em>

  • 根据北美组织病理学服务市场的详细趋势分析确定潜在投资领域
  • 深入了解推动不同成瘾治疗药物需求的潜在因素支出最高的国家,并确定每个国家提供的机会。
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展的了解,
  • 确定推动北美组织病理学服务市场的主要渠道 清晰地描绘未来的机会,这将有助于分析,从而增加收入。
  • 通过关注不同国家/地区正在进行的项目来引导资源 北美组织病理学服务市场

 

北美组织病理学服务市场细分

按检查类型

< /p>
  • 手术标本
  • 乳房活检
  • 肺活检
  • 肾活检
  • 胃肠活检
  • 胰腺活检
  • 皮肤组织活检
  • 睾丸活检
  • 其他

最终用户

  • 诊断实验室和实验室参考实验室
  • 研究机构
  • 其他

按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

公司简介

  • < span>Sonic Healthcare Limited
  • 美国实验室控股公司
  • TPL Path Labs
  • < li>Cureline 全球转化 CRO
  • Targos
  • 实验病理学实验室公司 (EPL)< /li>
  • 查尔斯河实验室有限公司

 

 

North America Histopathology Services Strategic Insights

Strategic insights for North America Histopathology Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-histopathology-services-market-strategic-framework.webp
Get more information on this report

North America Histopathology Services Report Scope

Report Attribute Details
Market size in 2021 US$ 9,283.83 Million
Market Size by 2028 US$ 13,902.74 Million
Global CAGR (2021 - 2028) 5.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 检查种类
  • 手术标本
  • 乳腺活检
  • 肺活检
  • 肾活检
  • 胃肠道活检
  • 胰腺活检
  • 皮肤组织活检
  • 睾丸活检
By 最终用户
  • 诊断实验室和参考实验室
  • 研究机构
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Sonic Healthcare Limited
  • Laboratory Corporation of America Holdings
  • TPL Path Labs
  • Cureline Global Translational CRO
  • Targos
  • Experimental Pathology Laboratories Inc (EPL)
  • CHARLES RIVER LABORATORIES, INC.
  • Get more information on this report

    North America Histopathology Services Regional Insights

    The regional scope of North America Histopathology Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-histopathology-services-market-geography.webp
    Get more information on this report

    The List of Companies - North America Histopathology Services Market

    1. Sonic Healthcare Limited
    2. Laboratory Corporation of America Holdings
    3. TPL Path Labs
    4. Cureline Global Translational CRO
    5. Targos
    6. Experimental Pathology Laboratories Inc (EPL)
    7. CHARLES RIVER LABORATORIES, INC.
    Frequently Asked Questions
    How big is the North America Histopathology Services Market?

    The North America Histopathology Services Market is valued at US$ 9,283.83 Million in 2021, it is projected to reach US$ 13,902.74 Million by 2028.

    What is the CAGR for North America Histopathology Services Market by (2021 - 2028)?

    As per our report North America Histopathology Services Market, the market size is valued at US$ 9,283.83 Million in 2021, projecting it to reach US$ 13,902.74 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The North America Histopathology Services Market report typically cover these key segments-

  • 检查种类 (手术标本, 乳腺活检, 肺活检, 肾活检, 胃肠道活检, 胰腺活检, 皮肤组织活检, 睾丸活检)
  • 最终用户 (诊断实验室和参考实验室, 研究机构)
  • What is the historic period, base year, and forecast period taken for North America Histopathology Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Histopathology Services Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Histopathology Services Market?

    The North America Histopathology Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Sonic Healthcare Limited
  • Laboratory Corporation of America Holdings
  • TPL Path Labs
  • Cureline Global Translational CRO
  • Targos
  • Experimental Pathology Laboratories Inc (EPL)
  • CHARLES RIVER LABORATORIES, INC.
  • Who should buy this report?

    The North America Histopathology Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Histopathology Services Market value chain can benefit from the information contained in a comprehensive market report.